Jason Aryeh

Affiliations

  • Director at Ligand Pharmaceuticals Inc (LGND), 2020-06-12
  • Large Shareholder, Other at Merrimack Pharmaceuticals Inc (MACK), 2019-07-18
  • Director at Aralez Pharmaceuticals Inc. (ARLZ), 2017-05-24
  • Director at Novelion Therapeutics Inc. (NVLN), 2017-05-17
  • Director at Immunomedics Inc (IMMU), 2017-01-11
  • Director at Myrexis Inc. (MYRX), 2012-06-20
  • Director at Nabi Biopharmaceuticals (NABI), 2011-05-27
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
LGND $87.01 750 Director 67,203 2019-09-03 Filing
LGND $90.01 746 Director 66,453 2019-08-05 Filing
LGND $93.00 754 Director 65,707 2019-07-31 Filing
LGND $100.22 3,000 Director 64,953 2019-07-30 Filing
LGND $106.01 250 Director 61,953 2019-07-29 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
LGND $241.81 26,862 Director 51,392 2018-08-17 Filing
LGND $245.00 1,080 Director 78,254 2018-08-16 Filing
LGND $176.47 4,000 Director 79,334 2018-03-09 Filing
LGND $174.88 3,500 Director 83,334 2018-03-08 Filing
LGND $155.00 3,417 Director 86,834 2018-02-23 Filing